---
figid: PMC8065760__pharmaceuticals-14-00322-g003
figtitle: Involvement of the significantly dysregulated microRNAs in renal cancer
  signaling pathways
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Danio rerio
- Homo sapiens
pmcid: PMC8065760
filename: pharmaceuticals-14-00322-g003.jpg
figlink: pmc/articles/PMC8065760/figure/pharmaceuticals-14-00322-f003/
number: F3
caption: Involvement of the significantly dysregulated microRNAs in renal cancer signaling
  pathways. Red arrows show the contribution of miRNAs to the development of RCC.
  As illustrated, miR-17-5p, miR-224 and miR-210 contribute to tumor growth by targeting
  the pathway of HIF-1α (Hypoxia inducible factor alpha), and its target, in normoxia
  and hypoxia conditions. Conversely, miR-155 impairs HIF-1α expression. The downregulation
  of tumor suppressor miR-126, miR-378, miR-100 and the upregulation of oncogenic
  miR-200b promote angiogenesis. Tumor growth, proliferation and metastasis depend
  on dysregulated miR-122, miR-153-5p and miR-205-5p which impact PI3k/Akt/mTOR (PI3K,
  phosphatidylinositol-3-kinase; AKT, protein kinase B; mTOR, mammalian target of
  rapamycin) signaling pathway and on the downregulation of miRNAs panel that promote
  epithelial to mesenchymal transition of renal cancer cells.
papertitle: 'The Ambivalent Role of miRNAs in Carcinogenesis: Involvement in Renal
  Cell Carcinoma and Their Clinical Applications.'
reftext: Federica Spadaccino, et al. Pharmaceuticals (Basel). 2021 Apr;14(4):322.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9573803
figid_alias: PMC8065760__F3
figtype: Figure
redirect_from: /figures/PMC8065760__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8065760__pharmaceuticals-14-00322-g003.html
  '@type': Dataset
  description: Involvement of the significantly dysregulated microRNAs in renal cancer
    signaling pathways. Red arrows show the contribution of miRNAs to the development
    of RCC. As illustrated, miR-17-5p, miR-224 and miR-210 contribute to tumor growth
    by targeting the pathway of HIF-1α (Hypoxia inducible factor alpha), and its target,
    in normoxia and hypoxia conditions. Conversely, miR-155 impairs HIF-1α expression.
    The downregulation of tumor suppressor miR-126, miR-378, miR-100 and the upregulation
    of oncogenic miR-200b promote angiogenesis. Tumor growth, proliferation and metastasis
    depend on dysregulated miR-122, miR-153-5p and miR-205-5p which impact PI3k/Akt/mTOR
    (PI3K, phosphatidylinositol-3-kinase; AKT, protein kinase B; mTOR, mammalian target
    of rapamycin) signaling pathway and on the downregulation of miRNAs panel that
    promote epithelial to mesenchymal transition of renal cancer cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - mir-210
  - sima
  - Vhl
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Mtor
  - Tor
  - Egfr
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - mir-124
  - mir-100
  - dpp
  - gbb
  - put
  - mav
  - mir155
  - mir210
  - mir122
  - hif1ab
  - vhl
  - mtor
  - egfra
  - mir126a
  - mir34a
  - vegfaa
  - egf
  - celsr1a
  - mir200b
  - MIR155
  - MIR210
  - MIR122
  - HIF1A
  - MIR17
  - MIR224
  - VHL
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - EGFR
  - MIR203A
  - MIR126
  - MIR34A
  - MIR378A
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - EGF
  - MIR100
  - TGFB1
  - TGFB2
  - TGFB3
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - MIR200B
  - VHL
---
